Divi's Laboratories Limited (NSE: DIVISLAB)

Divi's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	3,630	1,700	12,148	20,303	431.5
Short-Term Investments	-	33,350	39,630	15,269	505	110.1
Trading Asset Securities	-	-	-	-	-	9,714
Cash & Short-Term Investments	36,980	36,980	41,330	27,417	20,808	10,255
Cash Growth	-10.51%	-10.53%	50.75%	31.76%	102.91%	-27.34%
Accounts Receivable	-	21,560	17,930	24,239	16,765	14,134
Other Receivables	-	2,050	1,410	1,045	1,018	1,856
Receivables	-	23,610	19,340	25,283	17,783	15,990
Inventory	-	31,840	30,000	28,286	21,452	18,639
Prepaid Expenses	-	360	260	270.9	225	169.7
Other Current Assets	-	3,960	2,190	2,258	1,479	1,745
Total Current Assets	-	96,750	93,120	83,515	61,747	46,798
Property, Plant & Equipment	-	55,130	49,290	47,875	44,095	36,979
Long-Term Investments	-	820	770	720.1	0.1	0.1
Other Intangible Assets	-	40	50	74.9	49.5	36
Long-Term Deferred Tax Assets	-	100	140	144.7	32.3	43.8
Other Long-Term Assets	-	1,860	1,020	1,418	1,816	1,146
Total Assets	-	154,700	144,390	133,747	107,741	85,357
Accounts Payable	-	8,240	7,620	7,957	7,632	5,907
Accrued Expenses	-	2,440	2,550	3,235	2,486	1,889
Short-Term Debt	-	-	-	-	3.5	336.3
Current Portion of Leases	-	10	10	8.2	7.9	7.5
Current Income Taxes Payable	-	430	20	16.8	59.8	99.3
Current Unearned Revenue	-	10	10	7.6	6.4	5.4
Other Current Liabilities	-	1,650	800	731.3	929.3	1,024
Total Current Liabilities	-	12,780	11,010	11,956	11,125	9,268
Long-Term Leases	-	20	30	28.7	36.9	44.7
Long-Term Deferred Tax Liabilities	-	5,820	5,370	4,214	3,381	2,740
Other Long-Term Liabilities	-	370	310	267.1	252.5	205.2
Total Liabilities	-	18,990	16,720	16,465	14,795	12,258
Common Stock	-	530	530	530.9	530.9	530.9
Additional Paid-In Capital	-	800	800	798.8	798.8	798.8
Retained Earnings	-	134,120	126,090	115,797	91,480	71,636
Comprensive Income & Other	-	260	250	155.1	136.3	133.9
Shareholders' Equity	135,710	135,710	127,670	117,282	92,946	73,099
Total Liabilities & Equity	-	154,700	144,390	133,747	107,741	85,357
Total Debt	30	30	40	36.9	48.3	388.5
Net Cash (Debt)	36,950	36,950	41,290	27,380	20,760	9,867
Net Cash Growth	-10.51%	-10.51%	50.81%	31.89%	110.41%	-24.44%
Net Cash Per Share	139.19	139.19	155.54	103.14	78.20	37.17
Filing Date Shares Outstanding	265.43	265.47	265.47	265.47	265.47	265.47
Total Common Shares Outstanding	265.43	265.47	265.47	265.47	265.47	265.47
Working Capital	-	83,970	82,110	71,560	50,623	37,530
Book Value Per Share	511.21	511.21	480.92	441.79	350.12	275.36
Tangible Book Value	135,670	135,670	127,620	117,207	92,897	73,063
Tangible Book Value Per Share	511.06	511.06	480.73	441.51	349.93	275.22
Land	-	1,950	1,940	1,727	1,715	1,611
Machinery	-	48,610	45,770	39,860	33,535	25,292
Construction In Progress	-	7,780	2,120	4,699	7,106	9,197

Source: S&P Capital IQ. Standard template. Financial Sources.